| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.23 | 6e-07 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.29 | 8e-06 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.28 | 9e-05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.23 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.28 | 0.0003 |